The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte HANS-ULRICH DEMUTH, TORSTEN HOFFMANN,
KERSTIN KUHN-WACHE and FRED ROSCHE
__________
Appeal No. 2005-0412
Application No. 09/682,968
__________
ON BRIEF
__________
Before SCHEINER, ADAMS, and MILLS, Administrative Patent Judges.
ADAMS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on the appeal under 35 U.S.C. § 134 from the
examiner’s final rejection of claims 1-5, which are all the claims pending in the
application.
Claims 1 and 3 are illustrative of the subject matter on appeal and are
reproduced below:
1. A method of raising the blood sugar level in a mammal having
hypoglycemia by reducing degradation of glucagons, said
method comprising administering to said mammal a
therapeutically effective amount of an effector for reducing
enzymatic activity of dipeptidyl peptidase (DP IV) and DP IV-
analogous enzymes.
3. The method of claim 1, wherein the effector is selected from the
group consisting of DP IV enzyme inhibitors, substrates of DP
IV, pseudo-substrates of DP IV, inhibitors of DP IV expression,
proteins that bind DP IV or antibodies to DP IV and combinations
thereof.
Page: 1 2 3 4 5 6 7 Next
Last modified: November 3, 2007